ORX750, an Oral Orexin Receptor 2 Agonist, in Participants with Narcolepsy Type 1: Preliminary Results from a Phase 2a Trial Crossover Analysis

Plazzi G, Dauvilliers Y, Mignot E, Sterkel A, Leary EB, Yong L, Accardi MA, Kanes S. ORX750, an Oral Orexin Receptor 2 Agonist, in Participants with Narcolepsy Type 1: Preliminary Results from a Phase 2a Trial Crossover Analysis. Sleep 49(suppl_1), In Press.